Sublingual immunotherapy in children;Inmunoterapia sublingual en niños

Allergologia et Immunopathologia

Volumn 31, Issue 4, 2003, Pages 244-249

  Lleonart, R ^a   Munoz F ^a   Eseverri, J L ^a   Martinez Canabate A ^a   Tabar, A I ^a   Pedemonte, C ^a  

^a NONE

Author keywords

Adverse reactions; Children; Efficacy; Mechanism of action; Sublingual immunotherapy

Indexed keywords

ALLERGEN; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; HYMENOPTERA VENOM;

ALLERGIC DISEASE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; HUMAN; IMMUNOTHERAPY; MEDLINE; PEDIATRICS; REVIEW; SENSITIZATION; SIDE EFFECT;

EID: 0042326230     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1157/13050385     Document Type: Review

References (25)

1. Igea JM, Lázaro M, Quirce S. Inmunoterapia sublingual y oral. Rev Esp Alergol Inmunol Clin 1994;1:3-13.
2. Martorell A. Nuevas vías de administración de inmunoterapia. Allergol et Immunopathol 2000;28(3):81-109.
3. Kägi MK, Wütrich B. Different methods of local allergen-specific immunotherapy. Allergy 2002;57:379-88.
4. Passalaqua G, Canonica GW. Allergen-specific sublingual immunotherapy for respiratory allergy. BioDrugs 2001;16:509-19.
5. Bousquet J, Lockey RF, Malling HJ. WHO Position Paper Allergen Immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;44(53):2-42.
6. Malling H-J, Abreu-Nogueira L, Alvarez-Cuesta E, et al. EAACI/ESPACI position paper on local immunotherapy. Allergy 1998;53:933-44.
7. ARIA: Management of Allergic Rhinitis and its Impact on Asthma. J Allergy Clin Immunol 2001;108:S147-336.
8. La Rosa M, Ranno C, André C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425-32.
9. Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of standardized five-grass-pollen extract in rhinitis. Allergy 1998;53:493-8.
10. Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget AB, Tonnel AB et al. Sublingual swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999;54:249-60.
11. Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000;55:842-9.
12. Passalacqua G, Albano M, Riccio A, Fregonese L, Puccinelli P, Parmiani S, Canonica GW. Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: a doble-blind placebo-controlled study. J Allergy Clin Immunol 1999;104:964-8.
13. Marcucci F, Canonica GW, Parmiani S, Passalcqua G. Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications. Allergy 2001;56:1091-5.
14. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol 1990;18:277-84.
15. Vourdas D, Syrigou E, Potamianou P, Carat F, Batard, André, C et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. A double-blind, randomized, placebo-controlled study with 66 children. Allergy 1998;53:662-72.
16. Pradalier A, Basset D, Claudel A, et al. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops an sublingual tablets) versus placebo in seasonal rhinitis. A double-blind, randomized, placebo controlled study with 126 patients. Allergy 1999;54:819-28.
17. Caffarelli C, Sensi LG, Marcucci F, Cavagni G. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy 2000;55:1142-7.
18. Guez S, Vatrinet C, Fadel R, André C. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy 2000;55:369-75.
19. Hirsh Th, Sähn M, Leupold W. Double blind placebo controlled study of sublingual immunotherapy with house dust mite extracts in children. Pediatr Allergy Immunol 1997;8:21-7.
20. Quirino T, Iemoli E, Siciliani E, Parmiani S, Milazzo F. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy 1996;26:1253-61.
21. Di Rienzo V, Pagani A, Parmiani S, Passalacqua G, Canonica GW. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;55:1110-3.
22. André C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual-Swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121:229-34.
23. Torres Lima M, Wilson, D, Pitkin L, et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy 2002;32:507-14.
24. Patriarca G, Nucera E, Pollastrini E, et al. Sublingual desensitization: a new approach to latex allergy problem. Anesth Analg 2002;95:956-60.
25. Malling H. Is sublingual immunotherapy clinically effective? Curr Opin Clin Immunol 2002;2:523-531.